Orion quarterly operating profit jumps
HELSINKI Oct 23 (Reuters) - Finnish drug maker Orion reported a 17 percent rise in quarterly operating profit, managing to make up for a fall in sales of its Stalevo drug for Parkinson's disease with other products.
Orion said its third-quarter operating profit rose to 76.3 million euros from 65.3 million euros a year earlier.
Generic competitors dented sales of its Stalevo drug in the United States, but this was offset by compensation from Novartis and sales of other drugs, the company said. (Reporting by Helsinki newsroom)
- U.S. war veteran released by North Korea returns home |
- South Korea to make announcement on air zone; expansion is anticipated |
- Pro-Europe protesters gather for rally in Kiev
- Pennsylvania newlyweds "just wanted to murder someone together:" police
- Obama defends interim Iran deal, seeks to assure Israel